Drug–Drug Interaction Studies of Elagolix with Oral and Transdermal Low-Dose Hormonal Add-Back Therapy
Author:
Funder
AbbVie
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/s40262-020-00921-y.pdf
Reference31 articles.
1. Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–55. https://doi.org/10.1056/NEJMra1209993.
2. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–12. https://doi.org/10.1111/1471-0528.14640.
3. De La Cruz MS, Buchanan EM. Uterine fibroids: diagnosis and treatment. Am Fam Physician. 2017;95(2):100–7.
4. Al-Hendy A, Myers ER, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med. 2017;35(6):473–80. https://doi.org/10.1055/s-0037-1607264.
5. Soliman AM, Anand SB, Coyne KS, Castelli-Haley J, Snabes M, Owens CD. Examining the relationship between symptomatic burden and self-reported productivity losses among patients with uterine fibroids in the United States. J Occup Environ Med. 2017;59(10):974–81. https://doi.org/10.1097/JOM.0000000000001105.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed‐Dose Combination Product: Phase 1 Results in Healthy Pre‐ and Postmenopausal Women;Clinical Pharmacology in Drug Development;2024-04-09
2. GnRH agonists and antagonists in therapy of symptomatic uterine fibroids – current roles and future perspectives;Expert Opinion on Pharmacotherapy;2023-08-24
3. Contemporary approaches in the management of uterine leiomyomas;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-08
4. Combined Oral Contraceptives As Victims of Drug Interactions;Drug Metabolism and Disposition;2023-03-24
5. Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids;Expert Opinion on Drug Metabolism & Toxicology;2022-08-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3